To investigate accumulative aging effects on neurometabolism in human brain and to collect a reference dataset.
Introduction
Studies of normal aging in the human brain are important for neuroscientific research and clinical diagnosis. Magnetic resonance spectroscopy (MRS) provides a useful tool to study aging effects on brain metabolism.
1,2 While proton MRS ( 1 H-MRS) measured metabolites N-acetylaspartate (NAA), total choline (tCho), or total creatine (tCr) provide information about neuronal density and integrity (NAA), turnover of cell membrane (tCho), or energy metabolism (tCr), 1 the phosphorus MRS ( 31 P-MRS) measured adenosine-5 -triphosphate (ATP), phosphocreatine (PCr), phosphomonoesters (PME), phosphodiesters (PDE), or inorganic phosphate (Pi) allow insight into high-energy metabolism (ATP, PCr) and membrane synthesis (PME) or breakdown (PDE). [3] [4] [5] Depending on studied brain regions, methodology used, and characteristics of the subject populations, various relationships between age and changes in brain metabolites have been reported. 2, 4, 6, 7 One of the main reasons for the differences between prior studies may be due to variable rates of metabolite changes in different brain regions. Alternatively, a global assessment of brain metabolite changes may provide a measure of the overall burden of aging on the brain, 8 ie, the accumulative effects and the derived global metabolite concentrations (= mean concentration over the whole brain) are independent of specific brain regions, thus more comparable for different studies. However, to date few studies dealt with aging effect on global metabolite contents in human brain. Therefore, this study estimated age-related changes of global proton and phosphorus metabolite concentrations to investigate accumulative effects of normal aging in healthy human brain and also to collect a reference dataset for patient studies.
Methods Subjects
For this prospective, cross-sectional study healthy evenly agedistributed volunteers were recruited from the local population. Potential participants were initially interviewed by telephone talk about their clinical anamnesis to ensure that they met basic inclusion criteria (ie, no systemic diseases such as neurological/psychological disorders, chronic hypertension, diabetes, and hypercholesterol). In addition, each subject underwent two screening tests to exclude cognitive or psychiatric impairments: (1) The Beck Depression Inventory (BDI-II) including 21 multiple-choice questions for assessing depression; 9 ( 2) The DemTect including five short tasks with a maximum score of 18 for evaluating cognitive ability. 10 After excluding those subjects with abnormal results of screening tests (n = 4), body mass index (BMI) larger than 30 (n = 7), artifact in MR imaging (n = 1), abnormal morphological findings (n = 1), or incomplete MR examinations (n = 1) 54 subjects (26 females and 28 males aged from 22 to 73 years, mean vales = 44 ± 15 years, BMI = 23.9 ± 3.4, BDI-II score = 2 ± 2, and DemTect score = 17 ± 1) were finally included, with n ࣙ 5 per age decade for each gender. The study was approved by local institution review board and written consent was obtained from all subjects before the examinations.
MR Examinations
All MR examinations were carried out at 3T (Verio, Siemens, Erlangen, Germany 
Data Processing
EPSI data were analyzed with the MIDAS (Metabolite Imaging and Data Analysis System) package as described previously, to obtain volumetric maps of NAA, tCho, and tCr by using parametric spectral analysis. 12 The processing also calculated the relative tissue volume contribution to each MRSI voxel by applying a tissue segmentation procedure (FSL, http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/) to the T1-weighted MPRAGE data to map gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). Based on derived metabolite maps, global proton metabolite concentrations, presented as bracketed short name of each metabolite, eg, [NAA], [tCho] , and [tCr] (determined in ratio to internal water, presented as institutional unit), were obtained for each subject by using voxel-based analyses and averaging over all contributing voxels within the brain. Voxels with more than 30% CSF volume were excluded, while others were corrected for CSF volume contribution according to Met' = Met/(1 − f csf ) for 0 < f csf < 30%, where Met is the uncorrected metabolite signal intensity and f csf is the fraction of CSF in each MRSI voxel. Voxels with linewidth greater than 12 Hz were excluded. 11 The fractional volumes of the whole-brain tissue (FVTB), GM (FVGM), WM (FVWM), and CSF (FVCSF) were also derived correspondingly.
To (nicotinamide adenine dinucleotide), the spectra were processed with "LCModel" adapted for 31 P-MRS data, a software tool that originally analyzed 1 H-MRS data in the frequency domain using a linear combination of basis spectra, 13 with the basis spectra simulated with the VeSPA program as described previously by Wang et al. 14 As recommended by the author of LCModel, only 31 P metabolites estimated with a Cramer-Rao lower bound (CRLB) less than 15% were considered for further analysis to ensure the quality of the spectral fit (http://s-provencher.com/pub/LCModel/ manual/manual.pdf). Subsequently, values of NADH were excluded (the CRLB varied from 15% to 38% for more than 20% of the subjects). Each 31 P metabolite signal was then corrected for T1 saturation, with T1 values being estimated from in vivo measurements on a volunteer by using the nonlocalized 31 P-MRS sequence with TR values ranging from 1,700 to 10,000 milliseconds, which allowed T1 values to be calculated for each metabolite by a nonlinear fit of the signal intensity. After a coil loading correction based on the transmitter amplitude, each 31 P metabolite was calibrated by referencing to the 31 P phantom (in units mM). Decade mean values of each metabolite were also derived by averaging corresponding values of the subjects within each decade of age.
Statistical Analysis
Two sided t-tests were used to estimate gender differences of the data. Linear regression analysis was used to estimate the relationships between age and global brain metabolite concentrations or the fractional volumes of brain tissue. A Bonferroni-corrected significance level α was used for t-tests and linear regression analysis of three 1 H metabolites (.05/3 = .017), five 31 P metabolites (.05/5 = .01), and fractional volumes (.05/4 = .013). If the P value was between α and .05, the case was considered as not significant but showing a tendency. Pearson's correlation tests with uncorrected α = .05 were used to evaluate possible correlations between global metabolite concentrations and fractional brain tissue volume, as well as possible correlations between 1 H metabolites and 31 P metabolites, especially between tCho and PME or PDE, in vivo biomarker for metabolites concerning membrane turnover, and between tCr and ATP or PCr, in vivo biomarker for energy metabolism. SPSS version 24 (SPSS IBM, New York, USA) was used to perform the statistical analysis and Origin (OriginLab, Northampton, MA, USA) for the linear fits.
Results

Representative
1 H-metabolite maps of NAA, tCho, and tCr of a volunteer (22 years, female) derived from EPSI data with corresponding T1-weighted image at the level of centrum semiovale, and an example 1 H-MR spectrum of a voxel (red circle) are shown in Figure 1(A) . An example of a 31 P-MR spectrum acquired with nonlocalized single pulse with overlaid LCModel analysis (red line) is shown in Figure 1(B) .
Measured values of males and females were combined since no gender differences were found. Decade mean values of . NAA = Nacetylaspartate; tCho = total choline; tCr = total creatine; ATP = adenosine-5 -triphosphate; PCr = phosphocreatine; PME = phosphomonoesters; PDE = phosphodiesters; Pi = inorganic phosphate. a Concentrations of proton metabolites were measured in relation to internal tissue water, presented in institutional unit; those of phosphorus metabolites were calibrated with a 31 P phantom, in unit milli molar. SD = standard deviation; NAA = N-acetylaspartate; tCho = total choline; tCr = total creatine; ATP = adenosine-5 -triphosphate; PCr = phosphocreatine; PME = phosphomonoesters; PDE = phosphodiesters; Pi = inorganic phosphate.
global concentrations of all measured brain metabolites are given in Table 1 .
Global brain metabolite concentrations of all subjects are plotted versus age in Figure 2 , where the linear fits together with their 95% confidence bands are shown for metabolites that have significant correlations or a tendency of a correlation to age. Linear regression analysis (Table 2) Figure 3 : the FVCSF increased (from about .081 to .102) and the FVTB decreased (from about .915 to .894) with age, indicating a net age-related decrease of the brain tissue volume. Among the brain tissue, the FVGM decreased with age (from about .393 to .343), while the FVWM increased slowly (from about .523 to about .551), showing that the loss of the GM volume was the largest contribution to the decrease in brain tissue volume. Linear regression analyses confirmed these observations and revealed significant negative correlations of FVTB (R = −.57, −.46% per decade, P = .00001) and FVGM (R = −.70, −2.5% per decade, P < .00001) to age, and positive relation of FVWM (R = .48, 1.0% per decade, P = .0003) and FVCSF (R = .57, 5.4% per decade, P = .00001). Both 1 H-and 31 P-MR spectral linewidths did not show significant age correlations (P > .05).
With the whole age range, no significant correlation between 1 H and 31 P metabolites was found (P > .05). However, significant correlations between tCr and ATP (R = −.715, P = .02) and between tCr and PCr (R = −.753, P = .012) were found in subjects at age between 40 and 49 years. 
Discussion
This study measured global concentrations of the brain metabolites in healthy subjects by using a 1 H-wbMRSI with 70 milliseconds TE and a 31 7, 24 that are consistent with present findings. But measurements on small brain structures revealed regional dependent differences: In cerebral supraventricular WM and interhemispheric tissue of the medial frontal lobe age-independent tCho and tCr concentrations were found, 6 ,22 while lower tCho and tCr
Fig 2.
Global concentrations of the brain metabolites plotted versus age. Linear fits together with 95% confidence bands are shown for metabolites with significant (NAA, ATP, and PME) or a tendency (tCho, tCr, PCr, and Pi) of correlation to age. NAA = N-acetylaspartate; tCho = total choline; tCr = total creatine; ATP = adenosine-5 -triphosphate; PCr = phosphocreatine; PME = phosphomonoesters; PDE = phosphodiesters; Pi = inorganic phosphate. Concentrations of NAA, tCho, and tCr were determined in institutional unit (i.u.). Those of phosphorus metabolites were calibrated in mM. a Linear fit for age between 30 and 67 years. b Linear fit for age between 24 and 68 years. SD = standard deviation; NAA = N-acetylaspartate; tCho = total choline; tCr = total creatine; ATP = adenosine-5 -triphosphate; PCr = phosphocreatine; PME = phosphomonoesters; PDE = phosphodiesters; Pi = inorganic phosphate, FVCSF/GM/WM = fractional volume of the cerebrospinal fluid/gray matter/white matter; FVTB = fractional volume of brain tissue. Significance level α was .017 for 1 H metabolites, .01 for 31 P metabolites, and .013 for fractional volumes. α < P < .05 was considered as not significant but showing a tendency. concentrations in the cortical and subcortical GM of older subjects but not in the WM were reported. 23 These observations may suggest: First, the decrease of brain [NAA] with age seems to be a main process that could be detected with either local or global assessments. 22 4 Longo et al found significant increases with age for metabolite ratios PCr/(accumulated signal of all 31 P metabolites) and PCr/ATP. 25 These discrepancies might be attributed to the small brain volumes measured with a localized 31 P-MRS acquisition. Moreover, a larger cohort with evenly age distribution in the present study in comparison to those studied by Forester et al and Longo et al may also play a role. 25, 26 ATP and PCr are known as 31 P markers reflecting highenergy metabolism in human brain. ATP is the main source of chemical energy and reflects cellular oxidative phosphorylation and mitochondrial activities. PCr is an efficient temporal energy buffer and prevents a rapid decline in global ATP concentrations, mediated by the creatine phosphokinase reaction. 27, 28 In a study of nonhuman primate model of human aging, Pandya et al found that the aged animals had significantly reduced mitochondrial ATP synthesis capacity, which correlated with decline in motor function. 29 Histological studies revealed a decrease in number of mitochondria in aged organisms that is balanced by a significant increase in size, while oversized organelles do not result in a meaningful functional compensation. 30 Melov et al found in aging human brain an increase in the number and variety of mitochondrial DNA mutations in the brains of old individuals. 31 In line with these cellular findings of mitochondrial aging, [29] [30] [31] presently observed age-related decreases of ATP may provide in vivo evidence for reduced mitochondrial activity. Therefore, global ATP might be used as a biomarker for monitoring mitochondrial function in aging human brain. Present results for [PCr] can also shed light on age-related brain high-energy metabolism. Since PCr provides a phosphate group for ATP synthesis, the observations that over the age of 30 years global [PCr] decreased with age may indicate that with age its function as high-energy reservoir and the ability of building up a "phosphate reservoir" for brain ATP synthesis is reduced in older subjects. Therefore, old individuals might benefit from a dietary supplementation of creatine to compensate the PCr loss and to improve the high-energy brain metabolism. 32 Metabolites PME and PDE are related to phospholipid metabolism of cellular membrane, where PME contains membrane anabolites and PDE contains the membrane catabolites. 5 Correspondingly, the observations of decreased global [PME] und nearly unchanged [PDE] with age may reflect decreased membrane synthesis (PME) and an overall stable membrane breakdown (PDE) in older individuals. The fact that within the whole age range, no significant correlations were found between tCr and ATP or PCr that all are the biomarkers reflecting energy metabolism (except for subjects aged between 40 and 49 years) and between tCho and PME or PDE that all are the biomarkers reflecting membrane turnover, may suggest that the correlations between 1 H and 31 P metabolites vary with age, and a larger sample for each age decade may be necessary for detailed investigation. Agerelated changes of FVTB, FVCSF, and FVGM (Table 2) reflect that global brain tissue volume decreased with age, accompanied by increased CSF volume, while the loss of the GM volume (neuronal volume) was the largest contribution to the changes in brain tissue volume as reported before. We also found that the global FVWM increased slowly with age (Fig 3) . These findings are consistent with those measured on regional or global brain volumes. 7, 24, 33 While age-related decrease of NAA has been linked to changes of neuronal volume, neuronal activity, and density, 22 few studies to date provided a direct estimation of associations between them. 24 In this study, the simultaneous determinations of the global metabolite concentrations and the fractional volume of the GM allowed an evaluation of their correlation. As revealed by Pearson's correlation tests, weak but significant positive correlations to FVGM were found not only for age-related global [NAA] , which is consistent with earlier report, 24 but in addition also for global [ATP] , and [PME], and [Pi] .
There are several limitations of this study: The aging effects were estimated over the whole brain; thus, no information about changes in specific brain structures was obtainable. The use of a nonlocalized 31 P-MRS sequence suggests that measurements were less precise than those of 1 H-wbMRSI and the contributions from nonbrain tissue to brain 31 P metabolites may not be totally eliminated. For quantitation, the tissue water content used as internal reference for 1 H metabolites was assumed to be constant over the entire age range, which may impact the estimations, 12, 34 while the changes of brain water content with age were relatively small and less than the variability between the subjects. 35 In conclusion, this study demonstrated that the accumulative effects of normal aging brain are associated with reduced neuronal metabolic activity and/or density (decreased NAA), reduced mitochondrial activity (decreased ATP), and reduced membrane synthesis (decreased PME), with accompanied decrease of GM volume. Our findings have implications for the use of the techniques for studies on neurodegenerative diseases. Global NAA and ATP might be used as surrogate in vivo biomarkers for monitoring neuronal integrity and neuronal function.
